CBD Life Sciences Inc. (OTCMKTS:CBDL) Sees Significant Decrease in Short Interest
by Michael Walen · The Markets DailyCBD Life Sciences Inc. (OTCMKTS:CBDL – Get Free Report) saw a significant decline in short interest in December. As of December 31st, there was short interest totalling 39,500 shares, a decline of 88.3% from the December 15th total of 338,600 shares. Based on an average daily trading volume, of 75,074,700 shares, the short-interest ratio is currently 0.0 days.
CBD Life Sciences Trading Down 20.0 %
Shares of OTCMKTS CBDL traded down $0.00 during midday trading on Tuesday, reaching $0.00. The company’s stock had a trading volume of 9,691,416 shares, compared to its average volume of 23,433,617. CBD Life Sciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.03.
CBD Life Sciences Company Profile
CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.
See Also
- Five stocks we like better than CBD Life Sciences
- Are Penny Stocks a Good Fit for Your Portfolio?
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Roth IRA Calculator: Calculate Your Potential Returns
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- Conference Calls and Individual Investors
- Archer Aviation Shares Slide, Now Bargain Priced for 2025